Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand the common and serious side effects of Incruse Ellipta (umeclidinium) for COPD. Learn how to manage symptoms, when to seek medical attention, and essential precautions for safe medication use to ensure effective COPD management.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing difficult. Millions worldwide live with COPD, experiencing symptoms like shortness of breath, coughing, wheezing, and chest tightness. While there is no cure for COPD, various medications can help manage symptoms and improve quality of life. One such medication is Incruse Ellipta, an inhaled bronchodilator designed for the long-term maintenance treatment of COPD.
Incruse Ellipta, whose active ingredient is umeclidinium, belongs to a class of drugs called long-acting muscarinic antagonists (LAMAs). It works by relaxing the muscles around the airways in your lungs, making it easier to breathe. While it can significantly improve lung function and reduce symptoms, like all medications, Incruse Ellipta comes with potential side effects. Understanding these side effects, both common and serious, is crucial for patients, caregivers, and healthcare providers to ensure safe and effective treatment.
This comprehensive guide aims to provide detailed information on Incruse Ellipta side effects, including how the medication works, common and serious adverse reactions, precautions, drug interactions, and when to seek medical attention. By being well-informed, you can work more effectively with your doctor to manage your COPD and any potential medication-related concerns.
Incruse Ellipta is an inhalation powder containing umeclidinium, a long-acting anticholinergic medication. It is administered once daily using the Ellipta inhaler device. Its primary role is to provide maintenance treatment for COPD, meaning it is used regularly to prevent and control symptoms, not for immediate relief during an acute breathing episode (a rescue inhaler).
Umeclidinium works by blocking the action of acetylcholine, a neurotransmitter that causes the muscles around the airways to constrict. By blocking these muscarinic receptors in the lungs, umeclidinium helps relax the smooth muscles in the airways, leading to bronchodilation (widening of the airways). This relaxation allows air to flow more freely into and out of the lungs, reducing symptoms like shortness of breath and wheezing, and making breathing easier for individuals with COPD.
Because it is a long-acting medication, its effects last for approximately 24 hours, making a once-daily dosing schedule convenient for patients. It is important to remember that Incruse Ellipta is a preventive medication and should not be used to treat sudden breathing problems.
Like many medications, Incruse Ellipta can cause side effects. Most common side effects are mild to moderate and often resolve on their own as your body adjusts to the medication. However, it's important to be aware of them and discuss any concerns with your healthcare provider.
Headaches are one of the most frequently reported side effects. They are usually mild and can often be managed with over-the-counter pain relievers like ibuprofen or acetaminophen, if approved by your doctor. Staying hydrated and getting adequate rest can also help.
Symptoms such as a common cold, sore throat, or nasal congestion are sometimes reported. These are often viral infections and may not be directly caused by the medication but rather coincidental occurrences. However, if they are persistent or severe, consult your doctor. Practicing good hand hygiene can help reduce the risk of infections.
Similar to URTIs, these symptoms are common and generally mild. Gargling with salt water for a sore throat or using saline nasal sprays for congestion can offer relief.
Some individuals may experience an increase in coughing. If the cough becomes persistent, severe, or produces unusual phlegm, it's important to inform your doctor, as it could be a sign of a worsening condition or another issue.
UTIs are characterized by symptoms like painful urination, frequent urination, and a persistent urge to urinate. If you suspect a UTI, it's crucial to seek medical attention promptly, as untreated UTIs can lead to more serious complications. Staying well-hydrated may help prevent UTIs.
Some patients may experience muscle aches or joint pain. These symptoms are usually mild. Over-the-counter pain relievers and gentle stretching might help alleviate discomfort. If the pain is severe or persistent, discuss it with your doctor.
Gastrointestinal side effects, such as diarrhea or constipation, can occur. Maintaining a balanced diet, staying hydrated, and incorporating fiber can help manage these issues. If they become severe or persistent, consult your doctor.
Dry mouth is a common anticholinergic side effect. It can be uncomfortable and potentially increase the risk of dental problems. Sipping water frequently, chewing sugar-free gum, or using artificial saliva products can help. Good oral hygiene is essential.
A change in taste perception can occur, making food taste different or less appealing. This side effect is usually temporary and may improve over time. Staying hydrated and trying different foods might help mitigate the impact.
While less common with Incruse Ellipta compared to inhaled corticosteroids, any inhaled medication can potentially alter the oral flora and lead to oral thrush. Rinsing your mouth with water after each use of the inhaler can help prevent this fungal infection. If thrush develops, it will require antifungal treatment.
It is important to remember that not everyone will experience these side effects, and their severity can vary. Always discuss any bothersome or persistent side effects with your healthcare provider.
While less common, Incruse Ellipta can cause serious side effects that require immediate medical attention. Being aware of these signs and symptoms is crucial for your safety.
This is a rare but serious reaction where your breathing suddenly worsens, and you experience severe wheezing, coughing, or shortness of breath immediately after using your inhaler. This is the opposite of the intended effect. If this occurs, stop using Incruse Ellipta immediately and use your rescue inhaler. Seek emergency medical attention right away. Paradoxical bronchospasm can be life-threatening.
Anticholinergic medications like umeclidinium can worsen narrow-angle glaucoma or even precipitate an acute attack in susceptible individuals. Symptoms of acute narrow-angle glaucoma include:
If you experience any of these symptoms, especially if they are severe or sudden, seek emergency medical care immediately. Untreated acute glaucoma can lead to permanent vision loss. Inform your doctor if you have a history of glaucoma, especially narrow-angle glaucoma, before starting Incruse Ellipta.
Incruse Ellipta can cause or worsen urinary retention, particularly in men with an enlarged prostate (benign prostatic hyperplasia, BPH) or individuals with bladder neck obstruction. Symptoms of urinary retention include:
If you experience these symptoms, contact your doctor right away. Your doctor may need to adjust your medication or investigate the cause of the urinary problems.
While less common with inhaled anticholinergics compared to oral forms, Incruse Ellipta can potentially affect the heart. Possible cardiovascular side effects include:
If you experience new or worsening chest pain, a significantly increased heart rate, or an irregular heartbeat, seek medical advice promptly. Your doctor will assess whether these symptoms are related to the medication or another underlying condition.
Although rare, some individuals may experience a severe allergic reaction to Incruse Ellipta or its components. Signs of a severe allergic reaction include:
If you experience any signs of a severe allergic reaction, stop using the medication and seek emergency medical attention immediately.
Certain pre-existing conditions or circumstances can increase your risk of experiencing side effects or make Incruse Ellipta less safe for you. Always inform your doctor about your complete medical history before starting this medication.
Patients with a history of heart rhythm problems (arrhythmias), heart disease, or high blood pressure should use Incruse Ellipta with caution. Your doctor will weigh the benefits against the potential risks and monitor you closely for cardiovascular side effects.
If you have narrow-angle glaucoma or a history of it, Incruse Ellipta is generally contraindicated due to the risk of precipitating an acute attack. If you have open-angle glaucoma, discuss it with your doctor, as regular eye monitoring may be necessary.
Men with an enlarged prostate (BPH) or individuals with any form of bladder neck obstruction are at higher risk for urinary retention. Your doctor will assess this risk and monitor for symptoms.
While umeclidinium is primarily metabolized in the liver and excreted via feces and urine, significant impairment in kidney or liver function might alter its clearance. Use with caution in patients with severe impairment, and your doctor may adjust monitoring.
The safety of Incruse Ellipta during pregnancy and breastfeeding has not been extensively studied in humans. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. For breastfeeding mothers, it's unknown whether umeclidinium passes into breast milk. Discuss the risks and benefits with your doctor.
Incruse Ellipta is not approved for use in children or adolescents under 18 years of age. Its safety and efficacy have not been established in this population.
No overall differences in safety or effectiveness have been observed between elderly patients and younger patients. However, elderly patients may be more susceptible to anticholinergic side effects such as dry mouth or urinary retention due to age-related physiological changes or concomitant medications.
It's vital to inform your doctor about all medications you are currently taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements, to avoid potential drug interactions.
Concomitant administration of Incruse Ellipta with other anticholinergic-containing drugs (e.g., certain medications for irritable bowel syndrome, overactive bladder, or some antidepressants) can lead to an increased risk of anticholinergic side effects such as dry mouth, blurred vision, urinary retention, and constipation. Your doctor will review your medication list to avoid such combinations or monitor you closely.
Incruse Ellipta has been studied for interactions with other common COPD treatments, such as long-acting beta2-agonists (LABAs) and inhaled corticosteroids (ICS), and no clinically significant drug interactions have been identified. This means it can generally be safely used alongside these medications as part of a comprehensive COPD treatment plan.
Always consult your pharmacist or doctor if you are unsure about potential drug interactions.
Knowing when to seek medical advice is crucial for managing Incruse Ellipta side effects effectively and safely.
Regular follow-up appointments with your healthcare provider are essential to monitor your COPD condition and the effectiveness and safety of your treatment plan.
While some side effects are unavoidable, there are strategies you can employ to minimize their impact and ensure the safest use of Incruse Ellipta.
Always use Incruse Ellipta exactly as prescribed by your doctor. Do not use more or less than the recommended dose, and do not use it more frequently. Using it incorrectly or excessively can increase the risk of side effects.
Incorrect inhaler technique can lead to less medication reaching your lungs and potentially more depositing in your mouth and throat, increasing local side effects. Ask your doctor or pharmacist to demonstrate the correct way to use the Ellipta inhaler, and review the instructions for use that come with your medication.
Although Incruse Ellipta is not an inhaled corticosteroid, rinsing your mouth with water and spitting it out after each dose can help reduce the amount of medication left in your mouth, potentially decreasing the risk of dry mouth or oral irritation.
Drinking plenty of water throughout the day can help alleviate dry mouth and may also help prevent urinary tract infections.
Regular brushing and flossing are important, especially if you experience dry mouth, as it can increase the risk of dental problems.
Be open and honest with your healthcare provider about all your symptoms, medical history, and any concerns you have about your medication. They can provide personalized advice, adjust your treatment plan if necessary, or offer strategies to manage specific side effects.
Always have your short-acting beta-agonist (SABA) rescue inhaler with you for sudden breathing problems, as Incruse Ellipta is not for acute relief.
No, Incruse Ellipta is not a rescue inhaler. It is a long-acting maintenance medication used once daily to prevent and control COPD symptoms. You should always have a separate rescue inhaler (e.g., albuterol) available for sudden shortness of breath or acute breathing problems.
Common side effects like headache or dry mouth are often mild and may improve within a few days or weeks as your body adjusts to the medication. However, if side effects are persistent, severe, or bothersome, you should contact your doctor. Serious side effects require immediate medical attention.
Weight gain is not a commonly reported side effect of Incruse Ellipta in clinical trials. If you experience unexplained weight changes, discuss them with your doctor, as they may be related to other factors or underlying health conditions.
If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for a missed dose, as this could increase the risk of side effects.
Incruse Ellipta is designed for long-term maintenance treatment of COPD. Clinical studies support its safety and efficacy for continuous daily use over extended periods in appropriate patients. Your doctor will regularly assess your condition and the ongoing need for the medication.
Incruse Ellipta (umeclidinium) is an effective medication for the long-term management of COPD, helping to improve breathing and reduce symptoms. While it offers significant benefits, understanding its potential side effects is a vital part of safe and effective treatment. Most common side effects are mild and manageable, but it's crucial to be aware of the signs of serious adverse reactions, such as paradoxical bronchospasm, acute narrow-angle glaucoma, or urinary retention, which require immediate medical attention.
By adhering to your prescribed dosage, mastering proper inhaler technique, and maintaining open communication with your healthcare provider, you can minimize risks and optimize the benefits of Incruse Ellipta. Regular follow-up appointments allow your doctor to monitor your progress, address any concerns, and ensure your COPD management plan remains tailored to your needs. Always prioritize your health and do not hesitate to seek professional medical advice if you experience any concerning symptoms or have questions about your medication.
Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026
Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026